COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country
(This article will be updated continuously. It was originally published on January 28, 2020. It was last updated on July 27, 2021)
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ASEAN and Asia updated with the latest relevant regional news.
For specific updates concerning China and related business advisory, please click here.
Please refresh the page to get the latest updates.
ASEAN coronavirus updates (Live updates by country)
Brunei has joined the global Covax scheme and is expecting to have the COVID-19 vaccine in Q1 2021, having sourced enough supplies to cover 50% of the population. Discussions are on-going with other suppliers.
- Brunei saw eight new cases on July 24, taking the total to 321 amid three deaths.
- Brunei recorded two new cases on July 23, bringing the total to 313 amid three deaths.
- Brunei saw two new cases on July 22, taking the total to 311 amid three deaths.
Cambodia is expected to import vaccines from both China and Russia. China’s vaccines are still undergoing clinical trials while Russia has already commenced production. Australia has offered financial support to aid vaccine coverage in several southeast Asia countries including Cambodia.
- Cambodia saw 778 new cases and 22 deaths on July 26, bringing the tallies to 73,701 cases and 1,305 deaths.
- Cambodia reported 819 new cases and 29 deaths on July 25, taking the totals to 72,923 cases and 1,283 deaths.
- Cambodia saw 860 new cases and 32 deaths on July 24, taking the tallies to 72,104 cases and 1,254 deaths.
Indonesia has commenced vaccinations with just over nine million doses being given to front line workers from last month. China’s Sinovac is in discussions with Indonesia to provide supplies, however, the Government faces difficulties with a large population of 268 million and price sensitivity at Sinovac’s estimated costs at 200,000 rupiah (US$20) a dose. Indonesia’s Health Ministry’s Disease Control and Prevention Director-General Achmad Yurianto said that vaccinations would only be provided to citizens aged 18-59. The vaccine has also been required to pass halal certification prior to use and it is uncertain how the country can source enough vaccines to reach a sizeable part of its population. Australia has stated it will also provide financial support to solve these issues.
- Indonesia reported 28,228 new cases and 1,487 deaths on July 26, bringing the tallies to 3,194,733 cases and 84,766 deaths.
- Indonesia saw 38,679 new cases and 1,266 deaths on July 25, taking the totals to 3,166,505 cases and 83,279 deaths.
- Indonesia reported 45,416 new cases and 1,415 deaths on July 24, taking the tallies to 3,127,826 cases and 82,013 deaths.
Laos has been trialing the Russian Sputnik V vaccine and is also in discussions with China about acquiring supplies.
- Laos saw 223 new cases on July 26, bringing the total to 4,985 cases amid five deaths.
- Laos recorded 142 new cases on July 25, taking the total to 4,762 cases amid five deaths.
- Laos saw 278 new cases on July 24, bringing the total to 4,620 cases amid five deaths.
Malaysia is to provide vaccines free of charge to its nationals, but foreigners will need to pay for the treatment, according to the Malaysian Minister of Health, Tan Sri Muhyiddin Yassin, who has signed a deal with Pfizer for 12.8 million doses. These will be administered in two stages of 6.4 million people each, with the program to commence in Q1 2021. The country aims to inoculate between 80-100% of its citizens.
- Malaysia saw 14,516 new cases and 207 deaths on July 26, bringing the tallies to 1,027,954 cases and 8,201 deaths.
- Malaysia saw 17,045 new cases and 92 deaths on July 25, taking the totals to 1,013,438 cases and 7,994 deaths.
- Malaysia recorded 15,902 new cases and 184 deaths on July 24, taking the tallies to 996,393 cases and 7,902 deaths.
Myanmar is seeking assistance from the Gavi and Covax programs to acquire vaccines, while Australia is also providing financial relief. At present, the Government aims to treat 20 percent of the ‘most at risk’ in the country with vaccines. The Government is struggling with finances and logistics and is also under US sanctions, while cases are surging. The Government has banned the celebration of Christmas and other seasonal celebrations.
- Myanmar saw 4,630 new cases and 396 deaths on July 26, taking the totals to 274,155 cases and 7,507 deaths.
- Myanmar recorded 4,998 new cases and 355 deaths on July 25, taking the tallies to 269,525 cases and 7,111 deaths.
- Myanmar saw 5,657 new cases and 297 deaths on July 24, taking the totals to 264,527 cases and 6,756 deaths.
The Philippines aims to commence vaccinations from June 2021 and expects to inoculate about 25 million people (about 25 percent of its population) over the course of the year. The country has been badly affected by the virus and has the second-highest rate in Southeast Asia. The business community has reacted, more than 30 local companies signed an agreement to purchase at least 2.6 million vaccine doses from AstraZeneca in the country’s first such deal to secure coronavirus vaccines, ten days ago. They plan to donate a large part of the doses to the government for its planned vaccination program and use the rest to inoculate their employees.
- The Philippines saw 6,664 new cases and 23 deaths on July 26, taking the totals to 1,555,396 cases and 27,247 deaths.
- The Philippines recorded 5,749 new cases and 93 deaths on July 25, bringing the tallies to 1,548,755 cases and 27,224 deaths.
- The Philippines saw 6,216 new cases and 241 deaths on July 24, taking the totals to 1,543,281 cases and 27,131 deaths.
Singapore has been working on producing its own ‘Lunar’ vaccine, in a joint venture between the US company Arcturus together with the Duke-NUS medical school. It is a single dose, mRNA shot, developed from genetically engineering COVID-19 genes into an otherwise harmless virus. This technique is marginally safer than other vaccines which rely on dead Covid-19 material to provoke an immune response. The vaccine is expected to be available from Q1 2021. High-risk personnel will receive the vaccine first in a process to be determined by the government.
- Singapore saw 135 new cases on July 26, bringing the total to 64,314 cases amid 37 deaths.
- Singapore saw 125 new cases on July 25, taking the total to 64,179 cases amid 37 deaths.
- Singapore recorded 130 new cases on July 24 and one death, taking the total to 64,054 cases amid 37 deaths.
Thailand is currently expecting vaccines to be delivered in mid-2021. The doses would cover 13 million people in a population of about 69 million. Thailand’s National Vaccine Institute signed a non-refundable advance market commitment contract worth 2.38 billion baht (US$79 million) with AstraZeneca to reserve the supplies. Discussions are also on-going with Oxford University in the UK to secure a vaccine that could be available in Q1 if trials are completed in time.
- Thailand reported 15,376 new cases and 87 deaths on July 26, bringing the totals to 512,678 cases and 4,146 deaths.
- Thailand saw 15,335 new cases and 129 deaths on July 25, taking the tallies to 497,302 cases and 4,059 deaths.
- Thailand recorded 14,260 new cases and 119 deaths on July 24, bringing the totals to 481,967 cases and 3,930 deaths.
Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), a division of Vietnam’s Ministry of Health, has signed an agreement with Medigen Vaccine, a Taipei, Taiwan-based vaccine company to secure the supply of 3 million to 10 million COVID-19 vaccine doses in 2021. Medigen is currently conducting Phase II studies of the vaccine, co-developed with the USA’s National Institutes of Health (NIH), in Taiwan and Vietnam with a view to a Q1 2021 rollout.
Vietnam is also working on producing its own vaccine, with the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang City, partnering with New York City-based Icahn School of Medicine and the global health non-profit organization PATH. Phase 1 trials are already underway in Vietnam, while Phases 2 & 3 will be conducted at the beginning of 2021. The institute plans to submit documents for approval to the health ministry as early as April next year and claims to be capable of producing 30 million doses a year, expecting that a national vaccine could be distributed to the general population in October 2021.
As of July 26, 2021, Vietnam’s Ministry of Health confirmed a total of 101,173 cases of COVID-19. However, 19,342 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 524 deaths due to the pandemic. The latest community transmission cases have been reported from Ho Chi Minh City, Binh Duong, Tien Giang, Dong Nai, and Vinh Long Ninh among others.
- Vietnam saw 3,979 new cases and 31 deaths on July 25, taking the total to 94,913 cases amid 493 deaths.
Other Asian countries and Regions
Afghanistan faces two pandemics at the same time, Covid-19 and Polio. UNICEF is currently embarking on an urgent Polio vaccination program while the country is in talks with both China and Russia oversupplying COVID-19 vaccines. Government-imposed lockdowns increased conflict with the Taliban, and an overall lack of awareness of the disease has prevented many Afghani from obtaining treatment of either.
- As of July 26, Afghanistan has 145,008 cases and 6,515 deaths.
- Afghanistan has 144,285 cases and 6,480 deaths as of July 25.
- Afghanistan has 143,871 cases and 6,425 deaths as of July 24.
Bangladesh will receive 68 million doses of the COVID-19 vaccine from Gavi, which is committed to ensuring at least 20 percent of populations are inoculated. Each complete dose will cost about 200 Taka (US$2). The country is also in discussions with India concerning a further 30 million doses from the Serum Institute at about 450 Taka (US$5). Vaccinations are expected to commence in Q1 2021.
- As of July 26, Bangladesh has 1,179,827 cases and 19,521 deaths.
- Bangladesh has 1,164,635 cases and 19,274 deaths as of July 25.
- Bangladesh has 1.153,344 cases and 19,046 deaths as of July 24.
Bahrain has begun COVID-19 vaccinations for front line personnel using a joint Chinese-UAE Sinopharm product. Roll out among the general population is expected in Q1 2021.
- As of July 26, Bahrain has 268,626 cases and 1,383 deaths.
- Bahrain has 268,541 cases and 1,383 deaths as of July 25.
- Bahrain has 268,413 cases and 1,382 deaths as of July 24.
For specific updates concerning China, please click here.
For a complete overview of China’s vaccine availability please go here.
- China reported 76 new cases on July 26, bringing the total to 92,605.
- China recorded 32 new cases on July 25, taking the total to 92,529.
- China saw 35 new cases on July 24, taking the total to 92,497.
East Timor is receiving assistance from the Gavi Institute.
- East Timor has 10,348 cases and 26 deaths as of July 25.
- As of July 24, East Timor has 10,337 cases and 26 deaths.
- East Timor has 10,281 cases and 26 deaths as of July 23.
Hong Kong will provide COVID-19 vaccines free to all residents, with a vaccine being delivered in stages. The government has said it may take most of 2021 to reach 100 percent coverage for all citizens.
- Hong Kong has 11,979 cases and 212 deaths as of July 25.
- As of July 24, Hong Kong has 11,976 cases and 212 deaths.
- Hong Kong has 11,974 cases and 212 deaths as of July 23.
For a complete overview of India’s vaccine availability please go here.
- India has 31,439,764 cases and 421,411 deaths as of July 26.
- India has 31,409,639 cases and 420,996 deaths as of July 25.
- Our new India-specific updates can be found here.
Iran is jointly producing a COVID-19 vaccine with Russia, and the product has entered trials. National inoculation is expected to commence in September 2021.
- Iran has 3,723,246 cases and 89,122 deaths as of July 26.
- Iran has 3,691,432 cases and 88,800 deaths as of July 25.
- As of July 24, Iran has 3,664,286 cases and 88,532 deaths.
Iraq is currently in discussions with US company Pfizer concerning supplies of a COVID-19 vaccine. Supplies are expected in Q2 2021.
- Iraq has 1,564,828 cases and 18,347 deaths as of July 26.
- Iraq has 1,552,648 cases and 18,287 deaths as of July 25.
- As of July 24, Iraq has 1,543,501 cases and 18,232 deaths.
Japan is sourcing 145 million doses of vaccine from the United States and the UK and will be delivering them free of charge to all citizens commencing Q1 2021.
- Japan has 870,445 cases and 15,129 deaths as of July 26.
- Japan has 865,666 cases and 15,124 deaths as of July 25.
- As of July 24, Japan has 862,148 cases and 15,116 deaths.
Jordan is sourcing vaccines from Pfizer and expects to commence vaccinations from Q1 2021.
- Jordan has 766,114 cases and 9,971 deaths as of July 26.
- As of July 25, Jordan has 764,983 cases and 9,963 deaths.
- Jordan has 763,922 cases and 9,948 deaths as of July 24.
Kazakhstan has been developing its own vaccines with ‘Quazcovid’ being admitted by the WHO as a safe candidate. These are currently undergoing trials with a roll out expected in Q2 2021.
- As of July 26, Kazakhstan has 535,906 cases and 5,452 deaths.
- Kazakhstan has 529,269 cases and 5,382 deaths as of July 25.
- As of July 24, Kazakhstan has 522,638 cases and 5,244 deaths.
All citizens, including expatriates, will receive COVID-19 vaccines for free. Kuwait is importing one million vaccines from Pfizer, 1.7 million from Moderna, and three million doses of the Oxford-AstraZeneca vaccines and will commence a nationwide program from January.
- Kuwait has 393,605 cases and 2,293 deaths as of July 26.
- As of July 25, Kuwait has 392,617 cases and 2,284 deaths.
- Kuwait has 391,781 cases and 2,279 deaths as of July 24.
Kyrgyzstan is sourcing vaccines from Russia with the Sputnik V vaccine expected to be rolled out in Q2 2021.
- As of July 26, Kyrgyzstan has 158,120 cases and 2,261 deaths.
- Kyrgyzstan has 157,147 cases and 2,249 deaths as of July 25.
- As of July 24, Kyrgyzstan has 156,152 cases and 2,238 deaths.
Lebanon is sourcing vaccines from Pfizer and is expected to take deliveries from mid-February 2021.
- Lebanon has 555,643 cases and 7,894 deaths as of July 26.
- As of July 25, Lebanon has 555,302 cases and 7,892 deaths.
- Lebanon has 554,458 cases and 7,891 deaths as of July 24.
Macao is part of the Covax scheme and is expected to receive 1.4 million doses of vaccine. The product will cost Pataca 300 (US$40). Roll out is expected in late Q1 2021.
- Macau has 59 cases as of July 25.
- As of July 24, Macau has 58 cases.
- Macau has 55 cases as of July 4.
The Maldives will receive vaccines under the Covax program and will receive enough products to reach 20 percent of its population. Roll out is expected in Q2 2021.
- As of July 26, the Maldives has 76,848 cases and 219 deaths.
- The Maldives has 76,750 cases and 219 deaths as of July 25.
- The Maldives has 76,627 cases and 219 deaths as of July 24.
Mongolia is in discussions with Astra-Zeneca to purchase COVID-19 vaccines and is also part of the Covax scheme. Roll out is expected in Q2 2021.
- As of July 26, Mongolia has 157,974 cases and 782 deaths.
- Mongolia has 156,737 cases and 774 deaths as of July 25.
- Mongolia has 155,224 cases and 767 deaths as of July 24.
Nepal will source COVID-19 vaccines under the Covax program and will also purchase supplies from India. The rollout is expected from Q2 2021.
- Nepal has 682,947 cases and 9,738 deaths as of July 26.
- Nepal has 680,556 cases and 9,713 deaths as of July 25.
- As of July 24, Nepal has 679,017 cases and 9,695 deaths.
North Korea is expected to receive Covid-19 vaccines from China, with rumors that North Korean Leader Kim Jong-Un has already received treatment as part of medical trials.
- North Korea has reported its first case on July 25, the city of Kaesong is under lockdown.
Oman has sourced COVID-19 vaccines from Gavi and is buying additional supplies from Astra-Zeneca and Pfizer. Roll out will commence from January 2021 with each shot costing 10 Rial (US$24).
- As of July 26, Oman has 294,526 cases and 3,771 deaths.
- As of July 25, Oman has 293,954 cases and 3,753 deaths.
- Oman has 293,472 cases and 3,725 deaths as of July 24.
Pakistan is also suffering from a Polio epidemic and is struggling with dealing with both. However, it has stated it will provide the vaccine for free with national inoculations to start from April 2021.
- As of July 26, Pakistan has 1,008,446 cases and 23,048 deaths.
- Pakistan has 1,004,694 cases and 23,016 deaths as of July 25.
- Pakistan has 1,001,875 cases and 22,971 deaths as of July 24.
Israel is currently negotiating with the UAE to provide 1.5 million doses of vaccine to Palestine. The product is expected to be the Russian Sputnik V treatment and should be available to Palestinians in Q2 2021.
- As of July 25, Palestine has 316,088 cases and 3,599 deaths.
- Palestine has 315,968 cases and 3,596 deaths as of July 23.
- Palestine has 315,876 cases and 3,591 deaths as of July 21.
Qatar has signed an agreement with Moderna to provide Covid-19 vaccines and has also signed deals with Pfizer and BioNTech. These will be made available from late Q1 2021.
- Qatar has 225,376 cases and 600 deaths as of July 26.
- Qatar has 225,198 cases and 600 deaths as of July 25.
- As of July 24, Qatar has 225,072 cases and 600 deaths.
A complete overview of the availability and production of Russian Covid-19 vaccines and costs can be found here.
- Russia has 6,149,780 cases and 154,601 deaths as of July 26.
- Russia has 6,126,541 cases and 153,874 deaths as of July 25.
- Our new Russia-specific updates here.
Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) said last week that it had signed an agreement with the German biopharmaceutical company CureVac to provide Covid-19 vaccine. It plans to cover 70 percent of its population by the end of 2021 with treatment being available for free. The initial roll out is expected to be at the end of Q1 2021.
- Saudi Arabia has 519,395 cases and 8,179 deaths as of July 26.
- Saudi Arabia has 518,143 cases and 8,167 deaths as of July 25.
- As of July 24, Saudi Arabia has 516,949 cases and 8,155 deaths.
South Korea has reached a deal with AstraZeneca to purchase its coronavirus vaccine candidate and is in final talks with global drug-makers including AstraZeneca, Pfizer Inc, and Johnson & Johnson over their vaccines. It launched a preliminary review of AstraZeneca’s product in October for potential fast-track approval. Roll out is expected in Q1 2021.
- South Korea has 190,166 cases and 2,077 deaths as of July 26.
- South Korea has 188,848 cases and 2,073 deaths as of July 25.
- As of July 24, South Korea has 187,362 cases and 2,068 deaths.
Sri Lanka is to receive 4.2 million doses of the COVID-19 vaccine from Gavi, enough to cover 20 percent of the population. It has not yet released information on when these will be made available.
- As of July 26, Sri Lanka has 298,181 cases and 4,147 deaths.
- Sri Lanka has 296,516 cases and 4,099 deaths as of July 25.
- Sri Lanka has 294,850 cases and 4,054 deaths as of July 24.
Taiwan has been developing its own vaccine and is also part of the Covax scheme. It has stated it will be able to manufacture enough of its own product for 50 percent population coverage with roll-out expected in Q1 2021.
- Taiwan has 15,582 cases and 786 deaths as of July 26.
- Taiwan has 15,571 cases and 786 deaths as of July 25.
- As of July 24, Taiwan has 15,558 cases and 786 deaths.
Turkey has purchased 50 million doses of China’s Cornavac, manufactured by Sinopharm. These will be made available for free to the most at-risk population, inoculations start on December 11. Other treatments will be purchased and made available via medical outlets during the year and sold at cost price, and are likely to include products from Pfizer and Russia.
- Turkey has 5,618,417 cases and 50,997 deaths as of July 26.
- As of July 25, Turkey has 5,601,608 cases and 50,934 deaths.
- Turkey has 5,587,378 cases and 50,879 deaths as of July 24.
United Arab Emirates
The UAE is expected to authorize the use of China’s Sinopharm vaccine which is nearing the end of its clinical trials in the Emirates. The UAE’s Prime Minister, Sheikh Mohammed bin Rashid Al Maktoum was inoculated as part of the testing. Roll out is expected in Q1 2021. The UAE is also manufacturing the vaccine and hopes to produce between 75-100 million doses during the year.
- As of July 26, the UAE has 673,185 cases and 1,927 deaths.
- The UAE has 671,636 cases and 1,920 deaths as of July 25.
- The UAE has 670,108 cases and 1,916 deaths as of July 24.
Uzbekistan has been trailing China’s Anhui Zhifei Longcom Biopharmaceutical vaccine in addition to vaccines made by China’s Sinopharm and Russia’s Sputnik V. Roll out is expected in Q1 2021.
- Uzbekistan has 124,995 cases and 839 deaths as of July 26.
- As of July 25, Uzbekistan has 124,290 cases and 832 deaths.
- Uzbekistan has 123,559 cases and 826 deaths as of July 24.
Yemen is suffering from war and diseases such as diphtheria, while local politicians have made wild claims that the country will develop its own COVID-19 vaccine. It is a member of the Gavi program and relief is likely to come from humanitarian sources.
- Yemen has 7,012 cases and 1,373 deaths as of July 25.
- As of July 24, Yemen has 7,008 cases and 1,373 deaths.
- Yemen has 7,003 cases and 1,372 deaths as of July 23.
- China’s Support Policies for Businesses Under COVID-19: A Comprehensive List
- The China Sourcing Alternatives in ASEAN – Complimentary Country Guides
ASEAN Briefing is produced by Dezan Shira & Associates. The firm assists foreign investors throughout Asia and maintains offices throughout ASEAN, including in Singapore, Hanoi, Ho Chi Minh City, and Da Nang in Vietnam, Munich, and Esen in Germany, Boston, and Salt Lake City in the United States, Milan, Conegliano, and Udine in Italy, in addition to Jakarta, and Batam in Indonesia. We also have partner firms in Malaysia, Bangladesh, the Philippines, and Thailand as well as our practices in China and India. Please contact us at firstname.lastname@example.org or visit our website at www.dezshira.com.